EP. 1: An Introduction to MDS: Initial Diagnosis and Patient Risk Stratification
Naval G. Daver, MD introduces myelodysplastic syndrome (MDS), focusing on the typical disease course, role of biomarker testing and risk stratification.
EP. 2: Clinical Insights on the Treatment of Patients with High-Risk MDS
Dr. Daver reviews treatment goals and treatment options for patients with higher-risk MDS.
EP. 3: Targeting CD47 in MDS: Reviewing the CD47 Pathway and Key Trial Data
Subject-matter expert provides an overview of the CD47 pathway and shares how emergent trial data are impacting the MDS treatment landscape.
EP. 4: The Future of Treatment for Patients with MDS
Dr. Daver anticipates how the MDS landscape will evolve over time, emphasizing the importance of adopting targeted therapies.
